751 related articles for article (PubMed ID: 31288208)
21. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
Kiely JR; Patel AJK
J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
[TBL] [Abstract][Full Text] [Related]
22. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
Dessinioti C; Plaka M; Stratigos AJ
Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
[TBL] [Abstract][Full Text] [Related]
23. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
[TBL] [Abstract][Full Text] [Related]
25. Topical and systemic medical treatments of basal cell carcinoma.
Sollena P; Del Regno L; Fargnoli MC; Peris K
G Ital Dermatol Venereol; 2015 Aug; 150(4):429-34. PubMed ID: 26086413
[TBL] [Abstract][Full Text] [Related]
26. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE
Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302
[TBL] [Abstract][Full Text] [Related]
27. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
28. Emerging noninvasive treatments of nonmelanoma skin cancers.
Tongdee E; Psomadakis CE; Paka P; Marghoob N; Markowitz O
Cutis; 2020 Mar; 105(3):138-142;E5. PubMed ID: 32352432
[TBL] [Abstract][Full Text] [Related]
29. Basal cell carcinoma.
Gupta AK; Daigle D; Martin G
Skinmed; 2014; 12(1):33-8; quiz 38. PubMed ID: 24720082
[TBL] [Abstract][Full Text] [Related]
30. Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma.
Leavitt E; Lask G; Martin S
Curr Treat Options Oncol; 2019 Nov; 20(11):84. PubMed ID: 31773379
[TBL] [Abstract][Full Text] [Related]
31. Interventions for basal cell carcinoma of the skin.
Bath FJ; Bong J; Perkins W; Williams HC
Cochrane Database Syst Rev; 2003; (2):CD003412. PubMed ID: 12804465
[TBL] [Abstract][Full Text] [Related]
32. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.
Zloty D; Guenther LC; Sapijaszko M; Barber K; Claveau J; Adamek T; Ashkenas J;
J Cutan Med Surg; 2015; 19(3):239-48. PubMed ID: 25986316
[TBL] [Abstract][Full Text] [Related]
33. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
34. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.
Sekulic A; Migden MR; Lewis K; Hainsworth JD; Solomon JA; Yoo S; Arron ST; Friedlander PA; Marmur E; Rudin CM; Chang AL; Dirix L; Hou J; Yue H; Hauschild A;
J Am Acad Dermatol; 2015 Jun; 72(6):1021-6.e8. PubMed ID: 25981002
[TBL] [Abstract][Full Text] [Related]
35. The therapeutic dilemma of basal cell carcinoma in older adults: A review of the current literature.
Van Coile L; Verhaeghe E; Ongenae K; Destrooper L; Mohamadi Z; Brochez L; Hoorens I
J Geriatr Oncol; 2023 Apr; 14(3):101475. PubMed ID: 36990928
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.
Lebbe C; Becker JC; Grob JJ; Malvehy J; Del Marmol V; Pehamberger H; Peris K; Saiag P; Middleton MR; Bastholt L; Testori A; Stratigos A; Garbe C;
Eur J Cancer; 2015 Nov; 51(16):2396-403. PubMed ID: 26257075
[TBL] [Abstract][Full Text] [Related]
37. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer.
Marmur ES; Schmults CD; Goldberg DJ
Dermatol Surg; 2004 Feb; 30(2 Pt 2):264-71. PubMed ID: 14871220
[TBL] [Abstract][Full Text] [Related]
38. "Chemical" surgery in treating basal cell carcinoma in elderly.
Chiriac AE; Balan GG; Pinteala T; Chiriac A; Betiu M
Dermatol Ther; 2019 Jan; 32(1):e12753. PubMed ID: 30238579
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
[TBL] [Abstract][Full Text] [Related]
40. Occurrence of metachronous basal cell carcinomas: a prognostic model.
Smedinga H; Verkouteren JAC; Steyerberg EW; Hofman A; Nijsten T; Vergouwe Y
Br J Dermatol; 2017 Oct; 177(4):1113-1121. PubMed ID: 28664573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
